欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号UK/H/5582/001
药品名称Lifsar Pulmojet 50microgram/500microgram/dose inhalation powder
活性成分
    • Fluticasone propionate 500.0 µg
    • Salmeterol 45.0 µg
剂型Inhalation powder
上市许可持有人WINTHROP PHARMACEUTICALS UK LIMITED ONE ONSLOW STREET GUILDFORD SURREY GU1 4YS UNITED KINGDOM
参考成员国 - 产品名称United Kingdom (UK)
Lifsar Pulmojet 50microgram/500microgram/dose inhalation powder
互认成员国 - 产品名称
    • Liechtenstein (LI)
    • Lithuania (LT)
    • Bulgaria (BG)
许可日期2015/07/01
最近更新日期2020/06/24
药物ATC编码
    • R03AK06 salmeterol and fluticasone
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Initial Application
  • TypeLevel3：Other
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
    市场状态Positive
    ©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase